Intellia Therapeutics NTLA Earnings Call Transcripts

NASDAQ NTLA
$11.41 +0.24 (+2.15%)
As of: Nov 11, 2026 · 3:59 PM EST
11 earnings calls on file for Intellia Therapeutics, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Intellia Therapeutics Q2 2026 Earnings Call

Aug 6, 2026 5,765 words · 25 min read
  • John LeonardChief Executive Officer
  • Edward DulacChief Financial Officer
  • Jason FredetteVice President of Investor Relations and Corporate Communications
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Intellia Therapeutics Earnings Call Transcripts

Calls11
LatestAug 6, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 11 Intellia Therapeutics transcripts Register to get access to Intellia Therapeutics’s earnings call transcripts.